Asunto(s)
COVID-19 , Tuberculosis , Humanos , Pandemias , SARS-CoV-2 , Taiwán/epidemiología , Tuberculosis/diagnóstico , Tuberculosis/epidemiologíaAsunto(s)
Mycobacterium tuberculosis/aislamiento & purificación , Tuberculosis Urogenital/diagnóstico , Enfermedades Ureterales/microbiología , Infecciones Urinarias/microbiología , Femenino , Humanos , Inflamación , Persona de Mediana Edad , Tomografía Computarizada por Rayos X , Tuberculosis Urogenital/complicaciones , Enfermedades Ureterales/etiología , Infecciones Urinarias/complicacionesRESUMEN
BACKGROUND: Since the amendment of the Social Law V in Germany in 2007 the financial basis for a Specialised Home Palliative Care for Children (SHPC) for children was established. In Hesse 3 different SHPC teams entered into collective negotiations with health insurance companies. In 2014, the team of the University Children's Hospital in Giessen started to treat the first patient with a lead time of two months. METHODS: Thus in this paper the development of a SHPC team is described. After the first year anonymized patients data were retrospectively analyzed. RESULTS: Within 12 months 35 patients, 24 females and 11 males, were treated. All of the 6 patients who died, died at home. Calculated 48 weeks survival was 78%. 45% of the patients suffered from malignancies, 34% of malformations and 34% had metabolic disorders. 51% needed crisis intervention and 51% infusion therapy. Only 26% of parents denied cardiopulmonary resuscitation (CPR). Only 10% of the patients or their families received professional psychological care. CONCLUSION: Formation of a SHPC is feasible within a short time period once a financial basis is established. So, empathic guidance of families to help decision making for emergency situations are considered to be important. Analysis of patient's data after one year could help to improve the quality of care. Our data provides information for developing a palliative care team und could motivate colleagues to start the job.
Asunto(s)
Anomalías Congénitas/terapia , Servicios de Atención de Salud a Domicilio/organización & administración , Enfermedades Metabólicas/terapia , Neoplasias/terapia , Cuidados Paliativos/organización & administración , Grupo de Atención al Paciente/organización & administración , Adolescente , Causas de Muerte , Niño , Preescolar , Anomalías Congénitas/mortalidad , Femenino , Alemania , Servicios de Atención de Salud a Domicilio/legislación & jurisprudencia , Hospitales Universitarios , Humanos , Lactante , Recién Nacido , Masculino , Enfermedades Metabólicas/mortalidad , Programas Nacionales de Salud/legislación & jurisprudencia , Neoplasias/mortalidad , Cuidados Paliativos/legislación & jurisprudencia , Grupo de Atención al Paciente/legislación & jurisprudencia , Órdenes de Resucitación/legislación & jurisprudencia , Estudios Retrospectivos , Análisis de SupervivenciaAsunto(s)
Vólvulo Intestinal/diagnóstico por imagen , Mesenterio/diagnóstico por imagen , Procedimientos Quirúrgicos del Sistema Digestivo , Humanos , Aumento de la Imagen , Vólvulo Intestinal/diagnóstico , Vólvulo Intestinal/fisiopatología , Vólvulo Intestinal/cirugía , Masculino , Persona de Mediana Edad , Tomografía Computarizada por Rayos X , Resultado del TratamientoAsunto(s)
Infecciones por Bacteroides/complicaciones , Diálisis Peritoneal/efectos adversos , Peritonitis/microbiología , Anciano de 80 o más Años , Antiinfecciosos/uso terapéutico , Infecciones por Bacteroides/microbiología , Humanos , Fallo Renal Crónico/terapia , Masculino , Metronidazol/uso terapéuticoRESUMEN
We investigated the clinical characteristics of patients with pneumonia caused by Aeromonas species. Patients with pneumonia caused by Aeromonas species during the period 2004 to 2011 were identified from a computerized database of a regional hospital in southern Taiwan. The medical records of these patients were retrospectively reviewed. Of the 84 patients with pneumonia due to Aeromonas species, possible Aeromonas pneumonia was diagnosed in 58 patients, probable Aeromonas pneumonia was diagnosed in 18 patients, and pneumonia due to Aeromonas was conclusively diagnosed in 8 patients. Most of the cases of Aeromonas pneumonia developed in men and in patients of advanced age. A. hydrophila (n = 50, 59.5 %) was the most common pathogen, followed by A. caviae (n = 24, 28.6 %), A. veronii biovar sobria (n = 7, 8.3 %), and A. veronii biovar veronii (n = 3, 3.6 %). Cancer (n = 37, 44.0 %) was the most common underlying disease, followed by diabetes mellitus (n = 27, 32.1 %). Drowning-associated pneumonia developed in 6 (7.1 %) patients. Of 47 patients who were admitted to the intensive care ward, 42 patients developed acute respiratory failure and 24 of those patients died. The overall in-hospital mortality rate was significantly associated with liver cirrhosis, cancer, initial presentation of shock, and usage of mechanical ventilation. In conclusion, Aeromonas species should be considered as one of the causative pathogens of severe pneumonia, especially in immunocompromised patients, and should be recognized as a cause of drowning-associated pneumonia. Cirrhosis, cancer, and shock as the initial presenting symptom are associated with poor outcome.